Subin Kim

Subin Kim

Auto-generated profile, based on publicly available information

Subin Kim

Department of Genetics, Stanford University School of Medicine, Stanford, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
CYChristine Yiwen Yeh
Christine Yiwen Yeh
KAKarmen Aguirre
Karmen Aguirre
OLOlivia Laveroni
Olivia Laveroni
SKSubin Kim
Subin Kim
AWAihui Wang
Aihui Wang
LJLivnat Jerby
Livnat Jerby
The drivers of immune evasion are not entirely clear, limiting the success of cancer immunotherapies. Here we applied single-cell spatial and perturbational transcriptomics to delineate immune evasion in high-grade serous tubo-ovarian cancer. To this end, we first mapped the spatial organization of high-grade serous tubo-ovarian cancer by profiling more than 2.5 million cells in situ in 130 tumors from 94 patients. This revealed a malignant cell state that reflects tumor genetics and is predictive of T cell and natural killer cell infiltration levels and response to immune checkpoint blockade. We then performed Perturb-seq screens and identified genetic perturbations—including knockout of PTPN1 and ACTR8—that trigger this malignant cell state. Finally, we show that these perturbations, as well as a PTPN1/PTPN2 inhibitor, sensitize ovarian cancer cells to T cell and natural killer cell cytotoxicity, as predicted. This study thus identifies ways to study and target immune evasion by linking genetic variation, cell-state regulators and spatial biology.